ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) - ANVISA Registration 80254180386

Access comprehensive regulatory information for ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY (GBM) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180386 and manufactured by PHADIA AB. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, DR. FOOKE LABORATORIEN GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.